Search hospitals > California > Long Beach
Ark Clinical Research
Claim this profileLong Beach, California 90806
Global Leader in Coronavirus
Conducts research for Flu
Conducts research for Type 2 Diabetes
Conducts research for Eczema
Conducts research for COVID-19
38 reported clinical trials
5 medical researchers
Summary
Ark Clinical Research is a medical facility located in Long Beach, California. This center is recognized for care of Coronavirus, Flu, Type 2 Diabetes, Eczema, COVID-19 and other specialties. Ark Clinical Research is involved with conducting 38 clinical trials across 45 conditions. There are 5 research doctors associated with this hospital, such as Kenneth T Kim, Apinya Bee Vutikullird, Apinya Vutikullird, DO, and Martha G Navarro.Area of expertise
1Coronavirus
Global LeaderSARS-CoV-2
2Flu
estrogen
ER
Top PIs
Kenneth T KimGSK Investigational Site3 years of reported clinical research
Studies Asthma
Studies Coronavirus
5 reported clinical trials
13 drugs studied
Apinya Bee VutikullirdArk Clinical Research4 years of reported clinical research
Studies Cardiovascular Disease
Studies Type 2 Diabetes
4 reported clinical trials
8 drugs studied
Apinya Vutikullird, DOArk Clinical Research2 years of reported clinical research
Studies Norovirus Infection
Studies Norovirus
2 reported clinical trials
2 drugs studied
Martha G NavarroArk Clinical Research1 year of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
1 reported clinical trial
1 drug studied
Clinical Trials running at Ark Clinical Research
Type 2 Diabetes
Obesity
Diabetes
Cardiovascular Disease
Atopic Dermatitis
Sleep Disorders
Eczema
Chronic Kidney Disease
Flu
Bronchitis
Orforglipron vs Dapagliflozin
for Type 2 Diabetes
This trial is testing two medications, orforglipron and dapagliflozin, to see which one better controls blood sugar in people with type 2 diabetes who are not well-managed on metformin alone. Orforglipron lowers blood sugar levels, while dapagliflozin helps remove sugar through urine. The study will last several months. Dapagliflozin has been shown to improve blood sugar control in various studies.
Recruiting2 awards Phase 32 criteria
Orforglipron
for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Recruiting2 awards Phase 3
Retatrutide
for Type 2 Diabetes
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and inadequate glycemic control. The study will last about 11 months and may include up to 11 visits.
Recruiting1 award Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ark Clinical Research?
Ark Clinical Research is a medical facility located in Long Beach, California. This center is recognized for care of Coronavirus, Flu, Type 2 Diabetes, Eczema, COVID-19 and other specialties. Ark Clinical Research is involved with conducting 38 clinical trials across 45 conditions. There are 5 research doctors associated with this hospital, such as Kenneth T Kim, Apinya Bee Vutikullird, Apinya Vutikullird, DO, and Martha G Navarro.